TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.

<h4>Background</h4>Evidence suggests a confounding effect of mismatch repair (MMR) status on immune response in colorectal cancer. The identification of innate and adaptive immune cells, that can complement the established prognostic effect of CD8 in MMR-proficient colorectal cancers pat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Inti Zlobec, Eva Karamitopoulou, Luigi Terracciano, Salvatore Piscuoglio, Giandomenica Iezzi, Manuele Giuseppe Muraro, Giulio Spagnoli, Kristi Baker, Alexandar Tzankov, Alessandro Lugli
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9e52c81e1a5e42c096360efe9bddb208
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9e52c81e1a5e42c096360efe9bddb208
record_format dspace
spelling oai:doaj.org-article:9e52c81e1a5e42c096360efe9bddb2082021-11-18T07:01:50ZTIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.1932-620310.1371/journal.pone.0014282https://doaj.org/article/9e52c81e1a5e42c096360efe9bddb2082010-12-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21179245/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Evidence suggests a confounding effect of mismatch repair (MMR) status on immune response in colorectal cancer. The identification of innate and adaptive immune cells, that can complement the established prognostic effect of CD8 in MMR-proficient colorectal cancers patients, representing 85% of all cases, has not been performed.<h4>Methodology/principal findings</h4>Colorectal cancers from a test (n=1197) and external validation (n=209) cohort of MMR-proficient colorectal cancers were mounted onto single and multiple punch tissue microarrays. Immunohistochemical quantification (score 0-3) was performed for CD3, CD4, CD8, CD45RO, CD68, CD163, FoxP3, GranzymeB, iNOS, mast cell tryptase, MUM1, PD1 and TIA-1 tumor-infiltrating (TILs) reactive cells. Coexpression experiments on fresh colorectal cancer specimens using specific cell population markers were performed. In the test group, higher numbers of CD3+ (p<0.001), CD4+ (p=0.029), CD8+ (p<0.001), CD45RO+ (p=0.048), FoxP3+ (p<0.001), GranzymeB+ (p<0.001), iNOS+ (p=0.035), MUM1+ (p=0.014), PD1+ (p=0.034) and TIA-1+ TILs (p<0.001) were linked to favourable outcome. Adjusting for age, gender, TNM stage and post-operative therapy, higher CD8+ (p<0.001; HR (95%CI): 0.66 (0.64-0.68)) and TIA-1+ (p<0.001; HR (95%CI): 0.56 (0.5-0.6)) were independent prognostic factors. Moreover, among patients with CD8+ infiltrates, TIA-1 further stratified 355 (35.6%) patients into prognostic subgroups (p<0.001; HR (95%CI): 0.89 (95%CI: 0.8-0.9)). Results were confirmed on the validation cohort (p=0.006). TIA-1+ cells were mostly CD8+ (57%), but also stained for TCRγδ (22%), CD66b (13%) and only rarely for CD4+, macrophage and NK cell markers.<h4>Conclusions</h4>TIA-1 adds prognostic information to TNM stage and adjuvant therapy in MMR-proficient colorectal cancer patients. The prognostic effect of CD8+ TILs is confounded by the presence of TIA-1+ which translates into improved risk stratification for approximately 35% of all patients with MMR-proficient colorectal cancers.Inti ZlobecEva KaramitopoulouLuigi TerraccianoSalvatore PiscuoglioGiandomenica IezziManuele Giuseppe MuraroGiulio SpagnoliKristi BakerAlexandar TzankovAlessandro LugliPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 12, p e14282 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Inti Zlobec
Eva Karamitopoulou
Luigi Terracciano
Salvatore Piscuoglio
Giandomenica Iezzi
Manuele Giuseppe Muraro
Giulio Spagnoli
Kristi Baker
Alexandar Tzankov
Alessandro Lugli
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
description <h4>Background</h4>Evidence suggests a confounding effect of mismatch repair (MMR) status on immune response in colorectal cancer. The identification of innate and adaptive immune cells, that can complement the established prognostic effect of CD8 in MMR-proficient colorectal cancers patients, representing 85% of all cases, has not been performed.<h4>Methodology/principal findings</h4>Colorectal cancers from a test (n=1197) and external validation (n=209) cohort of MMR-proficient colorectal cancers were mounted onto single and multiple punch tissue microarrays. Immunohistochemical quantification (score 0-3) was performed for CD3, CD4, CD8, CD45RO, CD68, CD163, FoxP3, GranzymeB, iNOS, mast cell tryptase, MUM1, PD1 and TIA-1 tumor-infiltrating (TILs) reactive cells. Coexpression experiments on fresh colorectal cancer specimens using specific cell population markers were performed. In the test group, higher numbers of CD3+ (p<0.001), CD4+ (p=0.029), CD8+ (p<0.001), CD45RO+ (p=0.048), FoxP3+ (p<0.001), GranzymeB+ (p<0.001), iNOS+ (p=0.035), MUM1+ (p=0.014), PD1+ (p=0.034) and TIA-1+ TILs (p<0.001) were linked to favourable outcome. Adjusting for age, gender, TNM stage and post-operative therapy, higher CD8+ (p<0.001; HR (95%CI): 0.66 (0.64-0.68)) and TIA-1+ (p<0.001; HR (95%CI): 0.56 (0.5-0.6)) were independent prognostic factors. Moreover, among patients with CD8+ infiltrates, TIA-1 further stratified 355 (35.6%) patients into prognostic subgroups (p<0.001; HR (95%CI): 0.89 (95%CI: 0.8-0.9)). Results were confirmed on the validation cohort (p=0.006). TIA-1+ cells were mostly CD8+ (57%), but also stained for TCRγδ (22%), CD66b (13%) and only rarely for CD4+, macrophage and NK cell markers.<h4>Conclusions</h4>TIA-1 adds prognostic information to TNM stage and adjuvant therapy in MMR-proficient colorectal cancer patients. The prognostic effect of CD8+ TILs is confounded by the presence of TIA-1+ which translates into improved risk stratification for approximately 35% of all patients with MMR-proficient colorectal cancers.
format article
author Inti Zlobec
Eva Karamitopoulou
Luigi Terracciano
Salvatore Piscuoglio
Giandomenica Iezzi
Manuele Giuseppe Muraro
Giulio Spagnoli
Kristi Baker
Alexandar Tzankov
Alessandro Lugli
author_facet Inti Zlobec
Eva Karamitopoulou
Luigi Terracciano
Salvatore Piscuoglio
Giandomenica Iezzi
Manuele Giuseppe Muraro
Giulio Spagnoli
Kristi Baker
Alexandar Tzankov
Alessandro Lugli
author_sort Inti Zlobec
title TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
title_short TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
title_full TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
title_fullStr TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
title_full_unstemmed TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
title_sort tia-1 cytotoxic granule-associated rna binding protein improves the prognostic performance of cd8 in mismatch repair-proficient colorectal cancer.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/9e52c81e1a5e42c096360efe9bddb208
work_keys_str_mv AT intizlobec tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT evakaramitopoulou tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT luigiterracciano tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT salvatorepiscuoglio tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT giandomenicaiezzi tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT manuelegiuseppemuraro tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT giuliospagnoli tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT kristibaker tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT alexandartzankov tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
AT alessandrolugli tia1cytotoxicgranuleassociatedrnabindingproteinimprovestheprognosticperformanceofcd8inmismatchrepairproficientcolorectalcancer
_version_ 1718424059487715328